Science Talks // An Educational Webinar Series for Journalists organized with Wiley


In situations when reporters are uncertain about sources or interpreting the science is where the World Federation of Science Journalists (WFSJ) can help! The WFSJ provides ongoing training and support for new and seasoned reporters around the world. In partnership with Wiley, we are pleased to introduce to 10,000 science journalists globally and to everyone who is interested in a new series of webinars called Science Talks that are brought to you by The Wiley Network.


SAVE THE DATE FOR OUR UPCOMING WEBINARS

  • Tuesday 4 December at 11 am EST on Artificial Intelligence challenges and journalism

HOW DO I REGISTER FOR A WEBINAR?

Science Talks webinars are complimentary to WFSJ members and other science journalists interested in the subject. If you are not able to attend the live one-hour session the webinars will be recorded for later viewing on the WFSJ website.


#4th WEBINAR: ARTIFICIAL INTELLIGENCE AND JOURNALISM (Tuesday 4 December 2018)

Register here for the last free webinar in 2018 produced in collaboration with Wiley Publishers and get the facts on AI.

Participants will walk away with a deeper understanding of the:

– Differences between artificial intelligence, machine learning and deep learning
– Applications of AI and its social impact
– Challenges of implementing AI in key industries
– Cautionary tales from AI or machine learning gone wrong
– Reliable sources and experts in AI


#3rd WEBINAR: UNDERSTANDING HIV/AIDS FOR ACCURATE NEWS REPORTING (Tuesday 25 September 2018)


Our hosts for this 3rd Science Talks organized with Wiley Publishers were Dr. Kenneth Mayer and Dr. Annette Sohn from the International AIDS Society 

Media who view/review this webinar will learn more about:

• A brief history of human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS)
• What regions are most affected by HIV/AIDS, areas with an uptick in reported cases and the reasons for regional disparities
• How countries respond to the epidemic and the most effective tactics being used in the fight against HIV and AIDS
• Why the current approach to confronting the HIV/AIDS epidemic is drawing criticism; who are those critics and what is their impact on prevention and treatment options
• What treatments are available now and in the future
• Which sources of information are most reliable for journalists reporting on HIV and AIDS

SPEAKERS’ BIOGRAPHIES

Biographies of the three host speakers are available here.


#2nd WEBINAR: TACKLING EBOLA (24 July 2018)

View or review the webinar on Tackling Ebola


The second Science Talk on tackling Ebola took place on Tuesday 24 July at 11:00 am EST. In this session, Dr. Peter Halfmann, Research Associate Professor at the Influenza Research Institute at the University of Wisconsin, discussed the latest facts and figures on this infectious disease including news about vaccines.

Attendees learned more about:

  • The current situation in regions affected by the Ebola virus and if there is still any danger.
  • Where we stand with the research on finding a vaccine and if the latest human trials were successful.
  • When the vaccine will be made available for humans affected in regions by the Ebola virus.
  • What the future will bring in terms of infectious diseases, such as Ebola.
  • How local journalists can better report on infectious diseases including what they should look for, what kind of questions to ask, what resources they should use.

#1st WEBINAR: TRANSLATING COCHRANE HEALTH EVIDENCE (22 May 2018)

View or review our first webinar here. 


The first webinar, Science Talks with Cochrane took place on Tuesday, 22 May 2018 at 11:00 am ET.

In this session, Power of the Media – How to Translate Cochrane Health Evidence to Inform the Public, media learned:

  • How to use the Cochrane Library to support news stories covering important health subjects;
  • What sets Cochrane evidence aside from other types of health-related studies;
  • Why Cochrane evidence has rigorous quality standards;
  • The role of media in helping to translate medical evidence to help consumers make informed health decisions.

ABOUT COCHRANE
Cochrane is a global independent network of researchers, professionals, patients, carers and people interested in health.

Cochrane produces reviews which study all of the best available evidence generated through research and make it easier to inform decisions about health. These are called systematic reviews.

Cochrane is a not-for-profit organization with collaborators from more than 130 countries working together to produce credible, accessible health information that is free from commercial sponsorship and other conflicts of interest. Our work is recognized as representing an international gold standard for high quality, trusted information. Find out more at www.cochrane.org. Follow us on twitter @cochranecollab.


WEBINAR PARTNER

About The Wiley Network

Wiley believes the most successful individuals never stop learning. The Wiley Network draws on trusted Wiley authors, partners, and subject matter experts as well as professional leaders to share their knowledge and experiences to support learning and professional growth. Explore contributions from industry thought-leaders—from those with years of experience to those just starting out. Take advantage of white papers, infographics, interviews, opinion pieces, industry updates, videos, and more to help you stay ahead of the changing world. Customize your experience on The Wiley Network site by selecting your favourite subjects and interests.

About Wiley

Wiley, a global research and learning company, helps people and organizations develop the skills and knowledge they need to succeed. Our online scientific, technical, medical, and scholarly journals, combined with our digital learning, assessment and certification solutions help universities, learned societies, businesses, governments and individuals increase the academic and professional impact of their work. For more than 210 years, we have delivered consistent performance to our stakeholders. The company’s website can be accessed at www.wiley.com